Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation
Presentation and Q&A session scheduled for post-market on
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected].
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2025-results-presentation-302441429.html
SOURCE Ginkgo Bioworks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agog-Supported Works Win Two of Three Immersive Prizes at the 83rd Venice International Film Festival
- Apeing’s $0.0004 Presale Nears Its Next Stage: 410M+ Sold as Traders Eye the Next Big Crypto Beyond ETH and AVAX
- Nexbie 3D Printed Sneakers Review: Are They Worth Buying?
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share